Sandbox Reserved 1645
From Proteopedia
(Difference between revisions)
Line 14: | Line 14: | ||
== Microfibrils == | == Microfibrils == | ||
- | The Fibrillin-1 is an ubiquitous protein mostly expressed in muscles in its monomeric form. The monomers then polymerize to form the 10 to 12nm of diameter '''microfibrils'''. In the microfibrils the fibrillin-1 is associated to various proteins such as [[MAGP-1]], [[MAGP-2]], [[fibulin 2]] and [[fibulin 5]], [[elastin]], [[versicane]] and [[LTBP-1]]. Those microfibrils constitute the elastic and non-elastic human connective tissues such as the dermis or the organs. This protein plays an important role in the [[cytokine]] and growth factor regulation. | + | The Fibrillin-1 is an ubiquitous protein mostly expressed in muscles in its monomeric form. The monomers then polymerize to form the 10 to 12nm of diameter '''microfibrils'''. In the microfibrils the fibrillin-1 is associated to various proteins such as [[MAGP-1]], [[MAGP-2]], [[fibulin 2]] and [[fibulin 5]], [[elastin]], [[versicane]] and [[LTBP-1]]. Those microfibrils constitute the elastic and non-elastic human connective tissues such as the dermis or the organs. This protein plays an important role in the [[cytokine]] and growth factor regulation. <ref>Julien Wipff, Yannick Allanore, and Catherine Boileau. (2009). Interactions entre la Fibrilline-1 et le TGF-β. ''Médecine Sciences Paris'', volume (25). https://www.medecinesciences.org/en/articles/medsci/full_html/2009/02/medsci2009252p161/medsci2009252p161.html</ref> |
== Disease caused by mutation == | == Disease caused by mutation == | ||
- | The [https://en.wikipedia.org/wiki/Marfan_syndrome Marfan syndrome (MFS)] is a genetic disorder due to a mutation of the FBN1 gene. Because Fibrillin1 is found in connective tissues, having this syndrome can cause severe damages to the ocular, skeletal and cardiovascular systems by affecting the organs’ tissues. Indeed, with fragile connective tissues due to bad synthesized microfibrils, the aorta can be deformed and disrupted which can induce an internal bleeding, and lead to death. | + | The [https://en.wikipedia.org/wiki/Marfan_syndrome Marfan syndrome (MFS)] is a genetic disorder due to a mutation of the FBN1 gene. Because Fibrillin1 is found in connective tissues, having this syndrome can cause severe damages to the ocular, skeletal and cardiovascular systems by affecting the organs’ tissues. Indeed, with fragile connective tissues due to bad synthesized microfibrils, the aorta can be deformed and disrupted which can induce an internal bleeding, and lead to death. <ref>Marfan Syndrome.https://en.wikipedia.org/wiki/Marfan_syndrome Marfan syndrome</ref> |
- | It exists nearly a 1 000 of different mutations on this gene but the most common one is a substitution of a guanine by a thymine at the 1538 nucleotide of the transcript. This type of mutation leads to a non-synonymous amino acid substitution '''Cys (cysteine) to Phe (phenylalanine)''' at the 528 position on the fibrillin1 gene. Because this cysteine is present in the calcium binding domain's polypetide chain the epidermal growth factor-like domain's structure of FBN1 is modified by affecting the <scene name='86/868178/Disulfide_bridges/1'> disulfide bridge </scene> . The calcium cation cannot bind properly to the <scene name='86/868178/Ca_binding_site/1'> cb-EGF unit </scene> and therefore there is no stabilization of cb-EGF interdomain which causes defects in connective tissue. We can thus detect the marfan syndrome by an increase of TGF β in the blood because the factors cannot bind to the protein due to a change in the binding domain's structure. | + | It exists nearly a 1 000 of different mutations on this gene but the most common one is a substitution of a guanine by a thymine at the 1538 nucleotide of the transcript. This type of mutation leads to a non-synonymous amino acid substitution '''Cys (cysteine) to Phe (phenylalanine)''' at the 528 position on the fibrillin1 gene. Because this cysteine is present in the calcium binding domain's polypetide chain the epidermal growth factor-like domain's structure of FBN1 is modified by affecting the <scene name='86/868178/Disulfide_bridges/1'> disulfide bridge </scene> . The calcium cation cannot bind properly to the <scene name='86/868178/Ca_binding_site/1'> cb-EGF unit </scene> and therefore there is no stabilization of cb-EGF interdomain which causes defects in connective tissue. We can thus detect the marfan syndrome by an increase of TGF β in the blood because the factors cannot bind to the protein due to a change in the binding domain's structure. <ref>E. Martínez-Quintana, F. Rodríguez-González, P. Garay-Sánchez, and A. Tugoresb. (2014).A Novel Fibrillin 1 Gene Mutation Leading to Marfan Syndrome with Minimal Cardiac Features. ''Molecular Syndormology'', volume (5), 236-240.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188161/</ref> |
- | Other diseases can occur by the substitution of other cysteines of the FBN1 transcript such as C1, C2, C3, or C4. But the consequences of these mutations are much more severe. It shows the importance of the cysteines localization for the proteine's structure. Also, a mutation of the [https://en.wikipedia.org/wiki/TGF_beta_receptor_2 TGFBR2] gene coding for the TGF β has been found and can cause the "Type 2 Marfan syndrome". However, not much has been disovered on the subject yet. | + | Other diseases can occur by the substitution of other cysteines of the FBN1 transcript such as C1, C2, C3, or C4. But the consequences of these mutations are much more severe. It shows the importance of the cysteines localization for the proteine's structure. Also, a mutation of the [https://en.wikipedia.org/wiki/TGF_beta_receptor_2 TGFBR2] gene coding for the TGF β has been found and can cause the "Type 2 Marfan syndrome". However, not much has been disovered on the subject yet. <ref>p.A. Handford. (2000).Fibrillin-1, a calcium binding protein of extracellular matrix.''Biochimica et Biophysica Acta (BBA) - Molecular Cell Research'', volume (1498), 84-90.https://www.sciencedirect.com/science/article/pii/S0167488900000859</ref> |
== Structural highlights == | == Structural highlights == | ||
Line 28: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
+ | |||
== References == | == References == | ||
- | 1.[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188161/ A Novel Fibrillin 1 Gene Mutation Leading to Marfan Syndrome with Minimal Cardiac Features] | ||
- | + | <references/> |
Revision as of 11:50, 8 January 2021
This Sandbox is Reserved from 26/11/2020, through 26/11/2021 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1643 through Sandbox Reserved 1664. |
To get started:
More help: Help:Editing |
Fibrillin - 1
|
References
- ↑ Julien Wipff, Yannick Allanore, and Catherine Boileau. (2009). Interactions entre la Fibrilline-1 et le TGF-β. Médecine Sciences Paris, volume (25). https://www.medecinesciences.org/en/articles/medsci/full_html/2009/02/medsci2009252p161/medsci2009252p161.html
- ↑ Marfan Syndrome.https://en.wikipedia.org/wiki/Marfan_syndrome Marfan syndrome
- ↑ E. Martínez-Quintana, F. Rodríguez-González, P. Garay-Sánchez, and A. Tugoresb. (2014).A Novel Fibrillin 1 Gene Mutation Leading to Marfan Syndrome with Minimal Cardiac Features. Molecular Syndormology, volume (5), 236-240.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188161/
- ↑ p.A. Handford. (2000).Fibrillin-1, a calcium binding protein of extracellular matrix.Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, volume (1498), 84-90.https://www.sciencedirect.com/science/article/pii/S0167488900000859